BioSpace News Archive

Thermo Fisher Scientific Inc., the world leader in serving science, opened its largest single-use technology manufacturing site in Greater Nashville.

RegeneRx Biopharmaceuticals, Inc. has issued a Letter to Stockholders updating development of product candidates.

Nykode Therapeutics ASA announced it will report its financial results for the first half of 2022 on August 24, 2022 before market open and subsequently host a webcast presentation at 4 p.m. CET / 10 a.m. ET.

United Imaging Healthcare, a leading global medical imaging and radiotherapy equipment company, began trading on the Science and Technology Innovation Board of the Shanghai Stock Exchange.

Hemogenyx Pharmaceuticals plc, the biopharmaceutical group developing new therapies and treatments for blood diseases, announces the appointment of Mr Stuart Tinch as Director of Quality.

Gilead Sciences, Inc. announced that the European Commission has granted Marketing Authorization for Sunlenca® injection and tablets for the treatment of HIV infection, in combination with other antiretroviral, in adults with multi-drug resistant HIV infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.

LTS LOHMANN Therapie-Systeme AG announces the closing of the acquisition of Tapemark Inc. located in St. Paul, MN, USA.

Solasia Pharma K.K. officially announced that an organoarsenic drug “DARVIAS® Injection 135mg” has been launched today in Japan for use in relapsed or refractory Peripheral T-Cell Lymphoma.

Becton, Dickinson and Company (NYSE: BDX) (the " Company " or " BD ") today announced the early tender results for its previously announced Tender Offers (as defined below) to purchase for cash certain of its outstanding debt securities listed in the table below.

MAIA Biotechnology, Inc. today reported financial results for the second quarter ended June 30, 2022, and provided a corporate update.